Publikuar
This document identifies data elements and metadata to represent the information about tumor mutation burden (TMB) when reporting the value for the biomarker using clinical massive parallel DNA sequencing.
This document covers the TMB status and related metadata such as mutation type, sequencing types, and target areas of sequencing from human samples for clinical practice and research.
This document is not intended
— to define experimental protocols or methods for calculating the value of tumor mutation burden,
— for the other biological species, and
— for the Sanger sequencing methods.
PUBLISHED
ISO/TS 4424:2023
60.60
Standard published
11 dhj 2023
Only informative sections of projects are publicly available. To view the full content, you will need to members of the committee. If you are a member, please log in to your account by clicking on the "Log in" button.